EDURANT/rilpivirine — Percent Change (as a percent)
Johnson & Johnson EDURANT/rilpivirine — Percent Change (as a percent) increased by 1662.5% to 14.1% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.8%, from 10.7% to 14.1%. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Positive growth rates suggest strong market penetration or successful lifecycle management, whereas negative rates indicate potential market saturation or loss of market share to newer therapies.
Detailed definition
This metric measures the period-over-period percentage growth or decline in net sales for the EDURANT (rilpivirine) prod...
Peer comparison
Comparable to year-over-year or quarter-over-quarter revenue growth percentages reported for specific blockbuster drugs or key therapeutic assets by peer pharmaceutical firms.
jnj_segment_edurant_rilpivirine_percent_change_as_a_percentHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.3% | 9.6% | 1.8% | -14.3% | -5.2% | 7.6% | 12.8% | 18.6% | 21% | 15.7% | 11% | 11.5% | 10.7% | 21.6% | 16.4% | 0.8% | 14.1% |
| QoQ Change | — | +317.4% | -81.3% | -894.4% | +63.6% | +246.2% | +68.4% | +45.3% | +12.9% | -25.2% | -29.9% | +4.5% | -7.0% | +101.9% | -24.1% | -95.1% | >999% |
| YoY Change | — | — | — | -721.7% | -154.2% | — | +611.1% | +230.1% | +503.8% | +22.7% | -40.9% | -45.2% | -31.8% | +96.4% | +42.6% | — | +31.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's edurant/rilpivirine — percent change (as a percent)?
- Johnson & Johnson (JNJ) reported edurant/rilpivirine — percent change (as a percent) of 14.1% in Q1 2026.
- How has Johnson & Johnson's edurant/rilpivirine — percent change (as a percent) changed year-over-year?
- Johnson & Johnson's edurant/rilpivirine — percent change (as a percent) increased by 31.8% year-over-year, from 10.7% to 14.1%.
- What does edurant/rilpivirine — percent change (as a percent) mean?
- The percentage growth or decline in sales for the drug EDURANT compared to the previous period.